Overview

Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid Users

Status:
COMPLETED
Trial end date:
2023-04-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the abuse potential of gabapentin enacarbil immediate release capsules taken alone and in combination with oxycodone in healthy adult, non-dependent, recreational opioid users.
Phase:
PHASE4
Details
Lead Sponsor:
Arbor Pharmaceuticals, Inc.
Treatments:
1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic acid
Gabapentin
Oxycodone